Delivery Order SPE2DR25D1053-SPE2DR26FV620
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $25,475.56 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (30-count units) on January 14, 2026, with an ultimate completion date of January 15, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The Defense Logistics Agency awarded a delivery order valued at $47,448.98 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) on January 13, 2026, with an ultimate completion date of January 14, 2026. This firm fixed-price contract was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a...
- The Defense Logistics Agency awarded a delivery order valued at $17,747.75 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units). This firm fixed price delivery order, issued on November 25, 2025, with an ultimate completion date of November 26, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) under a firm fixed-price contract valued at $7,349.03. The award, issued on November 6, 2025, with an ultimate completion date of November 7, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform fulfillment from its corporate office location, leveraging its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $35,720.85 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) on January 7, 2026, with an ultimate completion date of January 8, 2026. This firm fixed-price, non-set-aside delivery order is performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (formerly operating as AmerisourceBergen), is...
- The Defense Logistics Agency awarded a $3,710.89 delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Gemtesa 75 mg tablets (90-count units). This non-set-aside, competitively awarded contract carries a firm fixed-price structure with an ultimate completion date of January 9, 2026, and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,059.40 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count) on November 26, 2025, with completion due by November 28, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating open competition among qualified pharmaceutical distributors. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order valued at $5,825.23 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (30-count units) on November 3, 2025, with an ultimate completion date of November 4, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $27,246.91 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count supply) on November 10, 2025, with an ultimate completion date of November 12, 2025. The award was made competitively with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $52,517.88 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (30-count units) on November 18, 2025, with completion scheduled for November 19, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract with performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract is issued under AmerisourceBergen's existing Indefinite Delivery...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FV620Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $35,688.67 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) with a firm fixed-price structure. This competitively awarded, non-set-aside order was executed on January 16, 2026, with an ultimate completion date of January 20, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at up to $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide. Through this flexible contracting mechanism, AmerisourceBergen fulfills critical pharmaceutical needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.7k | 1/15/26 |